Showing Results for
- Academic Journals (55,992)
Search Results
- 55,992
Academic Journals
- 55,992
- 1From:Nature (Vol. 596, Issue 7872) Peer-ReviewedThe emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines.sup.1,2. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the...
- 2From:Journal of Family Practice (Vol. 71, Issue 8) Peer-ReviewedWorldwide and across many diseases, vaccines have been transformative in reducing mortality--an effect that has been sustained with vaccines that protect against COVID-19. (1) Since the first cases of SARS-CoV-2...
- 3From:Nature (Vol. 586, Issue 7830) Peer-ReviewedA safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic.sup.1-8. For global deployment and pandemic control, a...
- 4From:Kasmera (Vol. 48, Issue 1) Peer-ReviewedEn enero de 2020, el agente etiológico responsable de un grupo de casos de neumonía grave en Wuhan, China, fue identificado como un nuevo Betacoronavirus (2019nCoV), el cual mostraba marcadas diferencias del SARS-CoV y...
- 5From:Revista Brasileira de Medicina do Trabalho (Vol. 19, Issue 2) Peer-ReviewedDear Editor, We would like to share some ideas on the article "Vaccination against COVID-19 in health care workers".1 Da Silva noted that "As occupational physicians, we will ever be in the front lines, but we should...
- 6From:Revista Brasileira de Medicina do Trabalho (Vol. 19, Issue 1) Peer-ReviewedDear reader, While COVID-19 has been a source of significant adversity, it has also allowed for advances in science and technology. The first wave of the pandemic was characterized by unfamiliarity. At that point, we...
- 7From:Colombia Medica (Vol. 53, Issue 3) Peer-ReviewedCase description: A 22-year-old female patient received the first dose of Pfizer-BioNTech vaccine (RNAm) against COVID-19; 6 days later, she presented abdominal pain located in the right hypochondrium and epigastrium,...
- 8From:SAMJ South African Medical Journal (Vol. 111, Issue 3) Peer-Reviewed2020 changed our lives. For too many it was the end of their life. For all of us, it heralded a new reality. During 2020 my social media feed was full of people wishing the year would end. I thought that little would...
- 9From:Dermatology News (Vol. 52, Issue 2)Evidence that a SARS-CoV-2 vaccine is associated with inflammatory reactions in patients with dermal fillers has led the American Society for Dermatologic Surgery to issue a guidance outlining the potential risk and...
- 10From:Saudi Medical Journal (Vol. 42, Issue 2) Peer-Reviewed16 January 2021--More than 2,800 scientists from 130 countries gathered on Friday (January 15) in a virtual forum hosted by the World Health Organization (WHO) to identify knowledge gaps and set research priorities for...
- 11From:Journal of Family Practice (Vol. 70, Issue 2) Peer-ReviewedPrioritized immunization is advised with the 2 COVID-19 vaccines. A third meningococcal ACWY vaccine is now the only one approved for those > 55 years. The year 2020 was challenging for public health agencies and...
- 12From:Journal of Clinical Investigation (Vol. 131, Issue 12) Peer-ReviewedRecently, there have been several reports of SARS-CoV-2 "breakthrough" infections that have occurred in recipients of the FDA-approved SARS-CoV-2 vaccines (1). These reports have the potential to undermine public...
- 13From:SAMJ South African Medical Journal (Vol. 111, Issue 5) Peer-ReviewedThe Democratic Republic of the Congo (DRC) declared the end of its 10th Ebola virus disease (EVD) outbreak on 25 June 2020. The outbreak was declared in North Kivu on 1 August 2018, and by the time it ended there had...
- 14From:Emerging Infectious Diseases (Vol. 27, Issue 11) Peer-ReviewedIn Israel, the BNT162b2 vaccine against severe acute respiratory syndrome coronavirus 2 was approved for use in adolescents in June 2021, shortly before an outbreak of B.1.617.2 (Delta) variant-dominant infection. We...
- 15From:Nature (Vol. 593, Issue 7859) Peer-ReviewedData from Qatar provide strongest evidence yet that COVID-19 vaccines can stop strains thought to pose a threat to immunization efforts. Data from Qatar provide strongest evidence yet that COVID-19 vaccines can stop...
- 16From:PLoS ONE (Vol. 16, Issue 12) Peer-ReviewedSARS-CoV-2 RT-PCR, the gold standard for diagnostic testing, may not be readily available or logistically applicable for routine COVID-19 testing in many rural communities in the United States. In this validation study,...
- 17From:Archives of Pediatric Neurosurgery (Vol. 3, Issue 1) Peer-ReviewedOn 11 March, the WHO confirmed coronavirus disease 2019 as a pandemic. The Director-General of the WHO called on governments to change its course by taking "urgent and aggressive action" (1). In terms of the number of...
- 18From:Infectious Diseases and Clinical Microbiology (Vol. 3, Issue 2) Peer-ReviewedThe burden of COVID-19 on healthcare workers (HCWs) is increasing day by day, particularly in countries with high incidence. Turkey was the fourth leading country after India, the USA and Brazil that reported the highest...
- 19From:BMC Oral Health (Vol. 21, Issue 1) Peer-ReviewedBackground Dentists are at high risk of exposure to occupational Coronavirus Disease 2019 (COVID-19). Since vaccination is crucial to control COVID-19 pandemic, we aimed to assess COVID-19 vaccination acceptance and...
- 20From:Emerging Infectious Diseases (Vol. 28, Issue 2) Peer-ReviewedPopulation-based data on coronavirus disease in Russia and on the immunogenicity of the Sputnik V vaccine are sparse. In a survey of 1,080 residents of Arkhangelsk 40-75 years of age, 65% were seropositive for IgG....